Treatment of vaginal bleeding irregularities induced by progestin only contraceptives

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 10, 2013, Pages

  Abdel Aleem, Hany ^a   d'Arcangues, Catherine ^b   Vogelsong, Kirsten M ^c   Gaffield, Mary Lyn ^d   Gülmezoglu, A Metin ^d  

^a Assiut University Faculty of Medicine   (Egypt)

^b Own Consultancy   (France)

^c BILL AND MELINDA GATES FOUNDATION   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; DELAYED RELEASE FORMULATION; DRUG COMBINATION;

CHEMICALLY INDUCED DISORDER; DELAYED RELEASE FORMULATION; DRUG COMBINATION; FEMALE; HUMAN; MENSTRUATION DISORDER; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; CHEMICALLY INDUCED; MENSTRUATION DISTURBANCES; THERAPEUTIC USE;

CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, SYNTHETIC; DELAYED-ACTION PREPARATIONS; DRUG COMBINATIONS; FEMALE; HUMANS; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MENSTRUATION DISTURBANCES; PROGESTINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84899470148     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003449.pub5     Document Type: Review

References (55)

1. Abdel-Aleem H, Shaaban OM, Amin AF, Abdel-Aleem AM. Tamoxifen treatment of bleeding irregularities associated with Norplant use. Contraception 2005;72:432-437. [: PMID 16307966]
2. Abdel-Aleem H, Shaaban OM, Abdel-Aleem MA, Fetih GN. Doxycycline in the treatment of bleeding with DMPA: a double-blinded randomized controlled trial. Contraception 2012;86:224-230. [DOI: ]
3. Alvarez-Sanchez F, Brache V, Thevenin F, Cochon L, Faundes A. Hormonal treatment for bleeding irregularities in Norplant implant users. American Journal of Obstetrics and Gynecology 1996;174:919-922.
4. Archer DF, Philput CB, Levine AS, Cullins V, Stoval TG, Bacon J, Weber ME. Effects of ethinyl estradiol and ibuprofen compared to placebo on endometrial bleeding, cervical mucus and the postcoital test in Levonorgestrel subcutaneous implant users. Contraception 2008;78:106-112.
5. Boonkasemsanti W, Reinprayoon D, Pruksananonda K, Niruttisard S, Triratanachat S, Leepipatpaiboon S, Wannakrairot P. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users. Human Reproduction 1996;11:115-123.
6. Buasang K, Taneepanichskul S. Efficacy of Celecoxib on controlling irregular uterine bleeding secondary to Jadelle use. J Med Assoc Thai 2009;92:301-7.
7. Cheng L, Zhu H, Wang A, Ren F, Chen J, Glasier A. Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel. Human Reproduction 2000;15:1969-1972.
8. d'Arcangues C, Piaggio G, Brache V, Aissa RB, Hazelden C, Massai R, Pinol A, Subakir SB, Su-juan G, Study Group on Progestogen-induced Vaginal Bleeding Disturbances. Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, in Norplant-induced prolonged bleeding. Contraception 2004;70:451-462. [: PMID 15541406]
9. Dempsey A, Roca C, Westhoff C. Vaginal estrogen supplementation during Depo-Provera initiation: a randomized controlled trial. Contraception 2010;82:250-255.
10. Diaz S, Croxatto HB, Pavez M, Belhadj H, Stern J, Sivin I. Clinical assessment of treatments for prolonged bleeding in users of Norplant implants. Contraception 1990;42:97-109.
11. El-Habashy MA, Mishell DR Jr, Moyer DL. Effect of supplementary oral estrogen on long-acting injectable progestogen contraception. Obstetrics and Gynecology 1970;35:51-54.
12. Gemzell-Danielsson K, van Heusden AM, Killick SR, Croxatto HB, Bouchard P, Cameron S, Bygdeman M. Improving cycle control in progestogen -only contraceptive pill users by intermittent treatment with a new anti-progestogen. Human Reproduction 2002;17:2588-2593.
13. Goldberg AB, Cardenas LH, Hubbard AE, Darney PD. Post-abortion depot medroxyprogesterone acetate continuation rates: a randomized trial of cyclic estradiol. Contraception 2002;66:215-220.
14. Harel Z, Biro F, Kollar L, Riggs S, Flangan P, Vaz R. Supplementation with vitamin C and/or vitamin B6 in the prevention of Depo-Provera side effects in adolescents. J Pediatr Gynecol 2002;15:153-158.
15. Jain JK, Nicosia AF, Nucatola DL, Lu JJ, Felix JC. Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate. Steroids 2003;68:1115-1119. [: PMID 14668006]
16. Johannisson E, Landgren BM, Diczfalusy E. Endometrial morphology and peripheral steroid levels in women with and without intermenstrual bleeding during contraception with 300 mcg Norethisterone (NET) Minipill. Contraception 1982;25:13-30.
17. Kaewrudee S, Taneepanichskul S, Jaisamraun U, Reinprayoon D. The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use. Contraception 1999;60:25-30.
18. Madden T, Proehl S, Allsworth JE, Secura GM, Peipert JE. Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial. American Journal of Obstetrics & Gynecology 2012;206(2):129.e 1-8.
19. Massai MR, Pavez MR, Fuentealba B, Croxatto H, d'Arcangues C. Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users. Contraception 2004;70:442-450.
20. Monteil-Seurin J, Bernard-Fernier MF, Martinaggi P, Demarez JP, Cauquil J, Lafont A. Evaluation of the efficacy of a ventonic capillary protector in the treatment of metrorrhagia due to IUD or micropill contraception [Appreciation de l'efficacite d'une association veinotonique protecteur capillaire comme traitment des metrorragies de la contraception par D.I.U. ou par micropilule]. Contraception-fertilité-sexualité 1985;13:721-725.
21. Nathirojanakun P, Taneepanichskul S, Sappakitkumjorn N. Efficacy of a selective COX-2 inhibitor for controlling irregular uterine bleeding in DMPA users. Contraception 2006;73:584-587.
22. Parker RA. The use of Quinesterol for the control of vaginal bleeding irregularities caused by DMPA. Contraception 1980;22:1-7.
23. Phaliwong P, Taneepanichskul S. The effect of Mefenamic acid on controlling irregular uterine bleeding second to Implanon use. J Med Assoc Thai 2004;87(Suppl 3):S64-8.
24. Phupong V, Sophonsritsuk A, Taneepanichskul S. The effect of tranexamic acid for treatment of irregular uterine bleeding secondary to Norplant use. Contraception 2006;73:253-256.
25. Sadeghi-Bazargani H, Ehdaeivand F, Arshi S, Eftekhar H, Sezavar H, Amanati L. Low-dose oral contraceptive to re-induce menstrual bleeding in amenorrheic women on DMPA treatment: A randomized clinical trial. Medical Science Monitor 2006;12:CR420-CR425.
26. Said S, Sadek W, Rocca M, Koetsawang S, Kirwat O, Piya-Anant M, Dusitsin N, Sethavanich S, Affandi B, Hadisaputra W, Kazi A, Ramos RM, d'Arcangues C, Belsey EM, Noonan E, Olayinka I, Pinol A, World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents For Fertility Regulation. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. Human Reproduction 1996;11:1-13. [: PMID 8982739]
27. Senthong A, Taneepanichskul S. The effect of Tranexamic acid for treatment irregular uterine bleeding secondary to DMPA use. J Med Assoc Thai 2009;92:461-5.
28. Subakir SB, Setiadi E, Affandi B, Pringgoutomo, Freisleben HJ. Benefits of vitamin E supplementation to Norplant users - in vitro and in vivo studies. Toxicology 2000;148:173-8. [: ISBN 3-928624-98-9]
29. Tantiwattanakul P, Taneepanichskul S. Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users. Contraception 2004;70:277-279.
30. Warner P, Guttinger A, Glasier AF, Lee RJ, Nickerson S, Brenner RM, Crtichley HOD. Randomized placebo-controlled trial of CDB-2914 in new users of a levonorgestrel-releasing intrauterine system shows only short-lived amelioration of unscheduled bleeding. Human Reproduction 2010;25:345-53.
31. Weisberg E, Hickey M, Palmer D, O'Connor V, Salamonsen L, Findlay JK, Fraser IS. A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon. Human Reproduction 2006;21:295-302.
32. Weisberg E, Hickey M, Plamer D, O'Connor V, Salamonsen LA, Findlay JK, Fraser IS. A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users. Human Reproduction 2009;24:1852-1861.
33. Witjaksono J, Lau TM, Affandi B, Rogers PA. Oestrogen treatment for increased bleeding in Norplant users: preliminary results. Human Reproduction 1996;11:109-114.
34. Archer DF, Philput CA, Weber ME. Management of irregular uterine bleeding and spotting associated with Norplant. Human Reproduction 1996;11:24-30.
35. Cseffalvay T, Klose S. (Estrogen-gestagen therapy with hormonally induced uterine bleeding.11.Therapeutic use of Klimovan). Deutsche gesundheitswesen 1965;20:1334-1339.
36. d'Arcangues C. Management of vaginal bleeding irregularities induced by progestin-only contraceptives. Human Reproduction 2000;15:24-29.
37. Glasier AF, Wang H, Davie JE, Kelly RW, Critchley HO. Administration of antiprogesterone up-regulates estrogen receptors in the endometrium of women using norplant: a pilot study. Fertility and Sterility 2002;77:366-372.
38. Piya-Anant M, Koetsawang S, Patrasupapong N, Dinchuen P, d'Arcangues C, Piaggio G, Pinol A. Effectiveness of cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea. Contraception 1998;57(1):23-28.
39. Sapire KE. A study of bleeding patterns with two injectable contraceptives given postpartum and the effect of two non-hormonal treatments. Advances in Contraception 1991;7:379-387.
40. Adeyemi, A. S, D. A. Adekanle. Progestogen-only injectable contraceptive: experience of women in Osogbo, southwestern Nigeria. Ann Afr Med 2012;11:27-31.
41. Affandi B. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon. Contraception 1998;58:99s-107s.
42. d'Arcangues C, Odlind V, Fraser IS. Dysfunctional uterine bleeding induced by exogenous hormones. In: Alexander NJ, d'Arcangues C editor(s). Steroid hormones and uterine bleeding. Washington: AAAS Press, 1992:81-105. [: ISBN 0-87168-508-6]
43. Datey S, Gaur LN, Saxena BN. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills) - an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research. Contraception 1995;51:155-165. [MEDLINE: PMID 7621684 UI 95347181]
44. Fan M, Sujuan G. Menstrual bleeding patterns in Chinese women using the Norplant subdermal implant. Human Reproduction 1996;11:14-19.
45. Fraser IS. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives. Contraception 1983;28:385-397.
46. Fraser IS, Tiitinen A, Affandi B, Brache V, Croxatto H, Diaz S, Ginsburg J, Gu S, Holma P, Johansson E, Meirik O, Mishell DR Jr, Nash HA, von Schoultz B, Sivin I. Norplant consensus statement and background review. Contraception 1998;57:1-9. [: PMID 9554244]
47. Grow DR, Reece MT, Hsiu JG, Adams L, Newcomb PM, Williams RF, Hodgen GD. Chronic antiprogestin therapy produces a stable atrophic endometrium with decreased fibroplast growth factor: a 1-year primate study in contraception and amenorrhea. Fertility and Sterility 1998;69(5):936-943. [: PMID 9591506]
48. Halliwell B, Gutteridge JM, Cross CE. Free radical, antioxidants and human disease: where are we now?. Journal of Laboratory and Clinical Medicine 1992;119:598-620.
49. Lukes AS, Kouides PA, Moore KA. Tranexamic acid: a novel oral formulation for the treatment of heavy menstrual bleeding. Womens Health (Lond Engl). 2011;7(2):151-8.
50. Newton JR, d'Arcangues C, Hall PE. A review of "once-a-month" combined injectable contraceptives. Journal of Obstetrics and Gynaecology 1994;4:S1-S34.
51. Nutley T, Dunson TR. Treatment of bleeding problems associated with progestin-only contraceptives: survey results. Advances in Contraception 1997;13:419-428.
52. Said S, Omar K, Koetsawang S, Kiriwat O, Srisatayapan Y, Kazi A, Ajmal F, Wynter HH, Pretnar-Darovec A, Benitez IB, World Health Organization, Task Force on Long-Acting Systemic Agents for Fertility Regulation, Special Programme of Research, Development and Research Training in Human Reproduction. A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: II. The comparison of bleeding patterns. Contraception 1987;35:591-610. [: PMID 2959448]
53. Shaaban MM, Elwan SI, el-Kabsh MY, Farghaly SA, Thabet N. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation. Contraception 1984;30:421-430. [: PMID 6440738]
54. Suvisaari J, Lahteenmaki P. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortion insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Contraception 1996;54:201-208.
55. Viegas OA, Singh K, Koh S, Singh P, Ratnam SS. The effects of Norplant on clinical chemistry in Singaporean acceptors after 1 year of use: I. Haemostatic changes. Contraception 1988;38:313-323. [: PMID 3139360]